Although the underlying mechanism between VEGF level and VTE risk is still unclear, our study has provided suggestive genetic evidence for a clinical concern to support the importance of VEGF assessments in monitoring and preventing the risk of VTE, especially DVT complicated by pulmonary embolism. This evidence concerns the gene VEGFA and pulmonary embolism.